Cheng Yu Chen
About Cheng Yu Chen
Company
Cheng Yu Chen is currently employed at Bristol Myers Squibb, a global biopharmaceutical company, in Cambridge, Massachusetts, United States. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Cheng Yu Chen holds the position of Senior Scientist at Bristol Myers Squibb, where his expertise and experience contribute to the company's mission of pioneering new treatments and therapies in the healthcare sector.
Education and Expertise
Cheng Yu Chen completed his Doctor of Philosophy (PhD) in Biochemistry at Duke University, studying from 2004 to 2013. Prior to that, he earned a Master of Science (MS) in Biochemistry, Biophysics, and Molecular Biology, as well as a Bachelor's degree in Life Science from National Tsing Hua University, where he studied from 1996 to 2002. He has over 20 years of experience in protein biochemistry, biophysics, enzymology, and molecular biology.
Professional Background
Cheng Yu Chen has held various research positions throughout his career. He worked as a Graduate Research Assistant at National Tsing Hua University from 2000 to 2003, followed by a Research Assistant role at the Institute of Biomedical Sciences, Academia Sinica in Taipei, Taiwan, from 2003 to 2004. He then held a Graduate Research Assistant position at Duke University from 2006 to 2013. From 2013 to 2015, he served as a Postdoctoral Research Associate at the Complex Carbohydrate Research Center, University of Georgia. He continued his postdoctoral research at the University of Arizona from 2015 to 2019. Subsequently, he was an Assistant Research Scientist at the University of Arizona from 2019 to 2020.
Achievements
Cheng Yu Chen is known for his dedication to mentoring and coaching younger colleagues, helping them develop scientific skills and critical thinking. His current and future interests lie in drug discovery within biomedical research, reflecting his commitment to advancing medical science and improving healthcare outcomes.